Mutagenesis and functional analysis of the pore-forming toxin HALT-1 from Hydra magnipapillata

Toxins

Volumn 7, Issue 2, 2015, Pages 407-422

  Mei Liew, Yvonne Jing ^a   Soh, Wai Tuck ^a   Jiemy, William Febry ^a   Hwang, Jung Shan ^a  

^a UCSI UNIVERSITY   (Malaysia)

Author keywords

Actinoporins; Cnidarians; Cytolysin; Equinatoxin II; Mutations; Pore forming protein

Indexed keywords

ALANINE; ASPARTIC ACID; BANDAPORIN; EQUINATOXIN II; GLUTAMIC ACID; HYDRA ACTINOPORIN LIKE TOXIN 1; LYSINE; SIGNAL PEPTIDE; STICHOLYSIN II; TOXIN; UNCLASSIFIED DRUG; MARINE TOXIN; PORE FORMING CYTOTOXIC PROTEIN; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CYTOLYSIS; EXPRESSION VECTOR; GENE MUTATION; GENETIC ANALYSIS; HEMOLYSIS; HUMAN; HUMAN CELL; HYDRA VULGARIS; MEMBRANE BINDING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STABILITY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; ANIMAL; DRUG EFFECTS; ERYTHROCYTE; GENETICS; HELA CELL LINE; HYDRA; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; MULTIGENE FAMILY; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

CNIDARIA; HYDRA; HYDRA MAGNIPAPILLATA;

AMINO ACID SEQUENCE; ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROCYTES; HELA CELLS; HEMOLYSIS; HUMANS; HYDRA; MARINE TOXINS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; MUTAGENESIS, SITE-DIRECTED; PORE FORMING CYTOTOXIC PROTEINS; RECOMBINANT PROTEINS;

EID: 84923204042     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins7020407     Document Type: Article

References (32)

1. Anderluh, G.; Pingercar, J.; Strukelj, B.; Macek, P.; Gubensek, F. Cloning, sequencing, and expression of equinatoxin II. Biochem. Biophys. Res. Commun. 1996, 18, 437–442.
2. Bernheimer, A.W.; Avigad, L.S. Properties of a toxin from the sea anemone Stoichacis helianthus, including specific binding to sphingomyelin. Proc. Natl. Acad. Sci. USA 1976, 73, 467–471.
3. Athanasiadis, A.; Anderluh, G.; Macek, P.; Turk, D. Crystal structure of the soluble form of equinatoxin II, a pore-forming toxin from the sea anemone Actinia equina. Structure 2001, 9, 341–346.
4. Hinds, M.G.; Zhang, W.; Anderluh, G.; Hansen, P.E.; Norton, R.S. Solution structure of the eukaryotic pore-forming cytolysin equinatoxin II: Implications for pore formation. J. Mol. Biol. 2002, 315, 1219–1229.
5. Mancheño, J.M.; Martín-Benito, J.; Martínez-Ripoll, M.; Gavilanes, J.G.; Hermoso, J.A. Crystal and electron microscopy structures of sticholysin II actinoporin reveal insights into the mechanism of membrane pore formation. Structure 2003, 11, 1319–1328.
6. Hong, Q.; Gutierrez-Aguirre, I.; Barlic, A.; Malovrh, P.; Kristan, K.; Podlesek, Z.; Macek, P.; Turk, D.; Gonzalez-Manas, J.M.; Lakey, J.H.; et al Two-step membrane binding by Equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic cluster and a flexible helix. J. Biol. Chem. 2002, 277, 41916–41924.
7. Malovrh, P.; Viero, G.; Serra, M.D.; Podlesek, Z.; Lakey, J.H.; Macek, P.; Menestrina, G.; Anderluh, G. A novel mechanism of pore formation: Membrane penetration by the N-terminal amphipathic region of equinatoxin. J. Biol. Chem. 2003, 278, 22678–22685.
8. Gutiérrez-Aguirre, I.; Barlic, A.; Podlesek, Z.; Macek, P.; Anderluh, G.; González-Mañas, J.M. Membrane insertion of the N-terminal α-helix of equinatoxin II, a sea anemone cytolytic toxin. Biochem. J. 2004, 384, 421–428.
9. Kristan, K.; Podlesek, Z.; Hojnik, V.; Gutiérrez-Aguirre, I.; Guncar, G.; Turk, D.; González-Mañas, J.M.; Lakey, J.H.; Macek, P.; Anderluh, G.; et al. Pore formation by equinatoxin, a eukaryotic pore-forming toxin, requires a flexible N-terminal region and a stable β-sandwich. J. Biol. Chem. 2004, 279, 46509–46517.
10. Belmonte, G.; Pederzolli, C.; Macek, P.; Menestrina, G. Pore formation by the sea anemone cytolysin equinatoxin II in red blood cells and model lipid membranes. J. Membr. Biol. 1993, 131, 11–22.
11. Hwang, J.S.; Ohyanagi, H.; Hayakawa, S.; Osato, N.; Nishimiya-Fujisawa, C.; Ikeo, K.; David, C.N.; Fujisawa, T.; Gojobori, T. The evolutionary emergence of cell type-specific genes inferred from the gene expression analysis of Hydra. Proc. Natl. Acad. Sci. USA 2007, 104, 14735–14740.
12. Glasser, E.; Rachamim, T.; Aharonovich, D.; Sher, D. Hydra actinoporin-like toxin-1, an unusual hemolysin from the nematocyst venom of Hydra magnipapillata which belongs to an extended gene family. Toxicon 2014, 91, 103–113.
13. Batista, U.; Macek, P.; Sedmak, B. The cytotoxic and cytolytic activity of equinatoxin II from the sea anemone Actinia equina. Cell Biol. Int. Rep. 1990, 14, 1013–1024.
14. Giraldi, T.; Ferlan, I.; Romeo, D. Antitumor activity of equinatoxin. Chem. Biol. Interact. 1976, 13, 199–203.
15. Kristan, K.; Viero, G.; Macek, P.; Serra, M.D.; Anderluh, G. The equinatoxin N-terminus is transferred across planar lipid membranes and helps to stabilize the transmembrane pore. FEBS J. 2007, 274, 539–550.
16. Anderluh, G.; Pungercar, J.; Krizaj, I.; Strukelj, B.; Gubensek, F.; Macek, P. N-Terminal truncation mutagenesis of equinatoxin II, a pore-forming protein from the sea anemone Actinia equina. Protein Eng. 1997, 10, 751–755.
17. Martinez, D.; Campos, A.M.; Pazos, F.; Alvarez, C.; Lanio, M.E.; Casallanovo, F.; Schreier, S.; Salinas, R.K.; Vergara, C.; Lissi, E.; et al. Properties of St I and St II, two isotoxins isolated from Stichodactyla helianthus: A comparison. Toxicon 2001, 39, 1547–1560.
18. García-Linares, S.; Castrillo, I.; Bruix, M.; Menéndez, M.; Alegre-Cebollada, J.; Martínez-del-Pozo, Á.; Gavilanes, J.G. Three-dimensional structure of the actinoporin sticholysin I. Influence of long-distance effects on protein function. Arch. Biochem. Biophys. 2013, 532, 39–45.
19. Pazos, F.; Valle, A.; Martínez, D.; Ramírez, A.; Calderón, L.; Pupo, A.; Tejuca, M.; Morera, V.; Campos, J.; Fando, R.; et al. Structural and functional characterization of a recombinant sticholysin I (rSt I) from the sea anemone Stichodactyla helianthus. Toxicon 2006, 48, 1083–1094.
20. Cilli, E.M.; Pigossi, F.T.; Crusca, E., Jr.; Ros, U.; Martínez, D.; Lanio, M.E.; Álvarez, C.; Schreier, S. Correlations between differences in amino-terminal sequences and different haemolytic activity of sticholysins. Toxicon 2007, 50, 1201–1204.
21. Anderluh, G.; Barlic, A.; Podlesek, Z.; Macek, P.; Pungercar, J.; Gubensek, F.; Zecchini, M.L.; Serra, M.D.; Menestrina, G. Cysteine-scanning mutagenesis of an eukaryotic pore-forming toxin from sea anemone: Topology in lipid membranes. Eur. J. Biochem. 1999, 263, 128–136.
22. Malovrh, P.; Barlic, A.; Podlesek, Z.; MaCek, P.; Menestrina, G.; Anderluh, G. Structure-function studies of tryptophan mutants of equinatoxin II, a sea anemone pore-forming protein. Biochem. J. 2000, 346, 223–232.
23. Álvarez, C.; Mancheño, J.M.; Martínez, D.; Tejuca, M.; Pazos, F.; Lanio, M.E. Sticholysins, two pore-forming toxins produced by the Caribbean Sea anemone Stichodactyla helianthus: Their interaction with membranes. Toxicon 2009, 54, 1135–1147.
24. Bakrac, B.; Anderluh, G. Molecular mechanism of sphingomyelin-specific membrane binding and pore formation by actinoporins. Adv. Exp. Med. Biol. 2010, 677, 106–115.
25. Anderluh, G.; Barlic, A.; Potrich, C.; Macek, P.; Menestrina, G. Lysine 77 is a key residue in aggregation of equinatoxin II, a pore-forming toxin from sea anemone Actinia equina. J. Membr. Biol. 2000, 173, 47–55.
26. Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T. The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling. Bioinformatics 2006, 22, 195–201.
27. Biasini, M.; Bienert, S.; Waterhouse, A.; Arnold, K.; Studer, G.; Schmidt, T.; Kiefer, F.; Cassarino, T.G.; Bertoni, M.; Bordoli, L.; et al. SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014, 42, W252–W258.
28. Worth, C.L.; Preissner, R.; Blundell, T.L. SDM—A server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Res. 2011, 39, W215–W222.
29. Capriotti, E.; Fariselli, P.; Casadio, R. I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005, 33, W306–W310.
30. Shapira, A.; Benhar, I. Toxin-based therapeutic approaches. Toxins 2010, 2, 2519–2583.
31. Tejuca, M.; Anderluh, G.; Serra, M.D. Sea anemone cytolysins as toxic components of immunotoxins. Toxicon 2009, 54, 1206–1214.
32. Choudhary, S.; Mathew, M.; Verma, R.S. Therapeutic potential of anticancer immunotoxins. Drug Dis. Today 2011, 16, 495–503.